Actuate Therapeutics Inc. - Bathi mangsa ngarep ACTU

ACTU (Actuate Therapeutics Inc.) - tandha merek perusahaan

Actuate Therapeutics, Inc. (ACTU) focuses on therapies for complex oncological diseases, avoiding direct price competition through the uniqueness of its developments. Professional management effectively manages capital following the IPO, ensuring data transparency. The financial forecast demonstrates business dynamics where the parameter value reaches . Growth in indicators is driven by progress in pancreatic cancer treatment, making the company an attractive acquisition target for biopharmaceutical behemoths.

ACTU: Bathi mangsa ngarep actuatetherapeutics.com 04.07.2022 - 18.11.2026

Actuate Therapeutics, Inc - rincian analitis lan metrik utama (ACTU)

Analisis fundamental perusahaan:actuatetherapeutics.com, ACTU
Barang utama Actuate Therapeutics Inc.

This indicator assesses the potential for cash flow recovery, identifying systemic degradation or the viability of the business model through projected future margins. By analyzing profit expectations, an investor can discern the resilience of Actuate Therapeutics, Inc. (ACTU), whose oncology revenues are independent of economic cycles and strictly tied to clinical trial milestones.

Pesaing utama

Bathi mangsa ngarep ONC|HALO: Penghasilan resik sing dikarepake|Bathi mangsa ngarep RVMD (RevMed)|AAPG (Ascentage) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CGON (cgoncology.com)|URGN - Bathi mangsa ngarep|BCAX: Bathi mangsa ngarep|PSNL - Proyeksi bathi mangsa ngarep|Erasca Corp (ERAS) - Bathi sing dikarepake|Delcath - Penghasilan resik sing dikarepake|YMAB (Y-mAbs Therapeutics Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Aura Biosciences, Inc. AURA|Proyeksi bathi mangsa ngarep CADL|Proyeksi bathi mangsa ngarep Accuray (ARAY)|Bathi sing dikarepake SELLAS Life Sciences Group Inc. SLS|Prakiraan bathi perusahaan Citius Oncology, Inc. (CTOR)|TuHURA Biosciences - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Protara Therapeutics, Inc.|FATE: Proyeksi bathi mangsa ngarep|WHWK - Prakiraan bathi perusahaan|Bathi sing dikarepake TScan Therapeutics, Inc.|Champions Oncology - Bathi forward|Proyeksi bathi mangsa ngarep XBIT|Prakiraan bathi perusahaan CEL-SCI Corp|Bathi sing dikarepake OS Therapies OSTX|Penghasilan resik sing dikarepake RADX|artivabio.com - Proyeksi bathi mangsa ngarep|Penghasilan resik sing dikarepake ANL (Adlai Nortye Ltd)|VERU (verupharma.com) - Bathi mangsa ngarep|TPST: Bathi resik mangsa ngarep|XLO (Xilio) - Proyeksi bathi mangsa ngarep|renovarobio.com (RENB) - Prakiraan bathi perusahaan|Bathi sing dikarepake Mural Oncology (MURA)|KAPA (Kairos Pharma Limited) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep OKUR (OnKure Therapeutics, Inc.)|Penghasilan resik sing dikarepake GDTC|Curis Inc. - Proyeksi bathi mangsa ngarep|APLM (apollomicsinc.com) - Prakiraan bathi resik|THAR: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Advanced Biomed Inc. (ADVB)|Bathi sing dikarepake Genprex, Inc|Proyeksi bathi mangsa ngarep calidibio.com|Bathi sing dikarepake Sunshine Biopharma (SBFM)|Xenetic Biosciences, Inc. - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep SLRX (salariuspharma.com)|Purple Biotech - Bathi sing dikarepake|AONC: Bathi mangsa ngarep|BGNE - Proyeksi bathi mangsa ngarep|CKPT (checkpointtx.com) - Bathi mangsa ngarep|Bathi resik sing dikarepake elevationoncology.com (ELEV)|Bathi mangsa ngarep ICAD|ikenaoncology.com (IKNA) - Prakiraan bathi perusahaan|Bathi sing dikarepake Notable Labs, Ltd. (NTBL)|Bathi sing dikarepake VIRX (Viracta Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep MOR (MorphoSys Inc)|Proyeksi bathi mangsa ngarep NAYA Biosciences Inc NAYA|AAPGV - Bathi sing dikarepake